Endo International PLC (ENDP.O) Quote| Reuters.com
United States

Endo International PLC (ENDP.O)

ENDP.O on Nasdaq

30 Jun 2016
Change (% chg)

$-0.34 (-2.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENDP.O


Endo International plc is a global specialty healthcare company focused on branded and generic pharmaceuticals and devices. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S.... (more)


Beta: 0.94
Market Cap(Mil.): $3,547.00
Shares Outstanding(Mil.): 222.66
Dividend: --
Yield (%): --


  ENDP.O Industry Sector
P/E (TTM): -- 34.76 35.71
EPS (TTM): -2.75 -- --
ROI: -4.13 15.00 14.23
ROE: -10.72 16.06 15.43

Highlights: Top U.S. hedge funds bet on Alphabet, Netflix and retailers

NEW YORK Former SAC executive Gabe Plotkin's Melvin Capital took a new position in streaming video service Netflix Inc, buying 950,000 shares and a call option for 1.45 million shares, according to regulatory filings on Monday. Melvin Capital also took a new position in Home Depot Inc, buying 475,000 shares. And Passport Capital added 3.3 million Yahoo Inc shares, upping its stake by 243 percent, filings show.

May 16 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : Wright Reports
Provider : ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.